Role of NOD2/CARD15 in coronary heart disease
2007

NOD2/CARD15 and Coronary Heart Disease

Sample size: 1532 publication Evidence: moderate

Author Information

Author(s): El Mokhtari Nour Eddine, Ott Stephan J, Nebel Almut, Schäfer Arne, Rosenstiel Philip, Förster Matti, Nothnagel Michael, Simon Rüdiger, Schreiber Stefan

Primary Institution: University Hospital Schleswig-Holstein, Kiel, Germany

Hypothesis

Is NOD2/CARD15 involved in the pathology of coronary heart disease?

Conclusion

NOD2 is up-regulated in atheroma lesions in coronary heart disease, but CARD15 genetic variants do not significantly contribute to the disease.

Supporting Evidence

  • NOD2 was detected in inflammatory cells in atheroma lesions.
  • No significant differences in CARD15 variant frequencies were found between CHD patients and controls.
  • The study included a large sample size of early-onset CHD patients.

Takeaway

This study looked at a gene called NOD2 to see if it affects heart disease. They found that while NOD2 is active in heart disease, the specific gene changes they studied don't seem to matter.

Methodology

The study analyzed NOD2 expression in coronary tissue and examined three CARD15 gene variants in 900 CHD patients and 632 healthy controls.

Limitations

The study only focused on three specific CARD15 variants and may not account for other genetic factors influencing CHD.

Participant Demographics

900 early-onset CHD patients (mean age 54, 83.7% male) and 632 healthy controls (mean age 62).

Statistical Information

Confidence Interval

0.67 to 1.14

Digital Object Identifier (DOI)

10.1186/1471-2156-8-76

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication